The FDA will no longer require regulatory approval for doctors to perform fecal transplants, provided the procedure is used only in patients with Clostridium difficile who have failed to respond to other treatments. In a statement, the FDA said it will "exercise enforcement discretion" and devise "appropriate policies for the study and use" of the procedure.
FDA drops plan to regulate fecal transplant procedures
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan